Home » Topics » BioWorld Science

BioWorld Science
RSS

Xortx reports promising phase II data with TMX-049 in type 2 diabetic nephropathy

Sep. 20, 2019

Takeda Pharmaceutical identifies somatostatin SST4 receptor agonists

Sep. 20, 2019

Caveolin-1 deficiency links type 2 diabetes to sporadic AD

Sep. 20, 2019

Annapurna Bio discovers apelin receptor agonists

Sep. 20, 2019

Incyte presents new adenosine A2A and/or A2B receptor antagonists

Sep. 20, 2019

Dart NeuroScience divulges new OPRL1 antagonists

Sep. 20, 2019

U.S. investigators patent KRAS mutant inhibitors

Sep. 20, 2019

Phase Ib data on IMCY-0098 in young adults with recent-onset type 1 diabetes presented

Sep. 20, 2019

SASH1 as a predictive biomarker for sensitivity to PARP inhibitors

Sep. 20, 2019

LUBAC identified as a biomarker of prognosis and potential therapeutic target in lung cancer

Sep. 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...